Elapegademase
CAS 1709806-75-6Biologic
Overview
Elapegademase is a recombinant pegylated enzyme indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID). It replaces the function of the deficient or malfunctioning ADA enzyme in patients.
Therapeutic areas
Genetic Disorders
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.